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Abstract
Following infection of the central nervous system (CNS), the immune system is faced with the challenge of eliminating the
pathogen without causing significant damage to neurons, which have limited capacities of renewal. In particular, it was
thought that neurons were protected from direct attack by cytotoxic T lymphocytes (CTL) because they do not express
major histocompatibility class I (MHC I) molecules, at least at steady state. To date, most of our current knowledge on the
specifics of neuron-CTL interaction is based on studies artificially inducing MHC I expression on neurons, loading them with
exogenous peptide and applying CTL clones or lines often differentiated in culture. Thus, much remains to be uncovered
regarding the modalities of the interaction between infected neurons and antiviral CD8 T cells in the course of a natural
disease. Here, we used the model of neuroinflammation caused by neurotropic Borna disease virus (BDV), in which virus-
specific CTL have been demonstrated as the main immune effectors triggering disease. We tested the pathogenic
properties of brain-isolated CD8 T cells against pure neuronal cultures infected with BDV. We observed that BDV infection of
cortical neurons triggered a significant up regulation of MHC I molecules, rendering them susceptible to recognition by
antiviral CTL, freshly isolated from the brains of acutely infected rats. Using real-time imaging, we analyzed the spatio-
temporal relationships between neurons and CTL. Brain-isolated CTL exhibited a reduced mobility and established stable
contacts with BDV-infected neurons, in an antigen- and MHC-dependent manner. This interaction induced rapid
morphological changes of the neurons, without immediate killing or impairment of electrical activity. Early signs of neuronal
apoptosis were detected only hours after this initial contact. Thus, our results show that infected neurons can be recognized
efficiently by brain-isolated antiviral CD8 T cells and uncover the unusual modalities of CTL-induced neuronal damage.
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Introduction
A better understanding of the interactions between viruses and
the central nervous system (CNS) represents a major issue in viral
pathogenesis. Indeed, viral persistence in the CNS represents a
challenge both for the host and the pathogen. On the virus side, it
is essential to adapt a strategy of replication that will minimize
virus-induced cell damage and limit its recognition by the immune
response. On the host side, it is essential to quickly halt virus
multiplication, while causing minimal damage to CNS resident
cells and in particular to neurons which have limited capacities of
renewal [1,2]. These issues are complicated by the unique
immunologic properties of the CNS, originally referred to as an
immune privileged site. It is now clear that this ‘‘privilege’’ is very
relative and that despite the blood-brain barrier and the absence of
dedicated lymphoid drainage [3], the immune response can
generally control invasion of the CNS by pathogens, although
often at the expense of irremediable tissue damage due to excessive
inflammation.
Among the different immune effectors involved in viral
elimination, CD8 T cells have received much attention, owing
to their essential roles in the primary protection of the host against
infectious diseases. CD8 cytotoxic T lymphocytes (CTL) mediate
their antiviral effects by recognizing viral peptides presented by
class I major histocompatibility complex (MHC I) molecules.
Upon engagement of the T cell receptor (TCR) with the peptide-
MHC I complex, CTL mediate cell killing essentially through two
independent pathways: perforin-dependent delivery of granzymes
and interaction of Fas-ligand (FasL) with the Fas-receptor on the
target cell surface. These lytic mechanisms could, however, have
devastating consequences in the CNS and it has been shown that
alternative non-cytolytic mechanisms can also be engaged by CTL
[4,5]. In particular, antiviral cytokines produced by CD8 T cells,
such as interferon gamma (IFN-c) or tumor necrosis factor alpha
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viral replication, resulting in complete or partial clearance from
the cell without destroying it. Furthermore, both mechanisms can
be combined to limit viral multiplication in the brain. One
example is infection with Herpes simplex virus type 1 (HSV-1), for
which latency is controlled by IFN-c produced by CD8 T and by
granzyme B-mediated degradation of the HSV-1 immediate early
protein ICP4 [6,7].
As recognition of peptide-MHC I complexes is essential to elicit
CTL effector functions, it has long been considered that neurons
were spared from CD8 T cell attack because they did not express
MHC I molecules [8,9]. Recent studies, however, have challenged
this view. First, accumulating evidence has revealed that MHC I
expression in the developing and adult CNS can have additional
non-immune functions. Indeed, neuronal MHC I molecules
appear to be crucial for normal brain development, neuronal
differentiation and plasticity [10,11]. In addition to their role in
CNS function, it was also shown that neurons could express MHC
I molecules under inflammatory conditions. For example, in
Rasmussen’s encephalitis, histopathological examination of autop-
sy material revealed the presence of granzyme B-containing CD8
T cells in direct apposition to MHC I positive neurons [12].
Further evidence of MHC I inducibility in neurons was provided
in vitro. Indeed, it has been shown that primary cultures of neurons
treated with IFN-c and electrically silenced using Tetrodotoxin
(TTX) can be induced to express MHC I molecules on their
surface [13]. This expression is functionally relevant, as CTL can
attack peptide-pulsed neurons in an antigen-specific manner in vitro
[14]. One caveat of such studies, however, is that they were
performed using neurons loaded with non-limiting amounts of
exogenous peptides. Moreover, CD8 T cells used in these assays
were either CTL clones or lines with pre-defined epitope
specificity, often derived for practical reasons from TCR-
transgenic animals. CTL were also often further differentiated in
vitro or restimulated in culture. Despite the above-mentioned
limitations, several studies using variations of this experimental
paradigm have provided considerable insight on MHC I-restricted
T cell interactions with neurons [2,15]. One still unsatisfactorily
resolved issue in neurovirology, however, is whether antiviral CD8
T cells can indeed recognize and directly attack virus-infected
neurons in the course of a natural disease.
Infection with Borna disease virus (BDV) appears as a very
suitable model system to address these questions. BDV is an
enveloped virus with a non-segmented, negative strand RNA
genome [16,17], which is characterized by a remarkable non-
cytolytic strategy of replication. BDV infects the CNS of a wide
variety of mammals [18,19] and induces a large spectrum of
neurological disorders [18,20,21]. One of the best-investigated
animal models for the pathogenesis of BDV infection is the Lewis
rat. After intracerebral infection, the rats develop an acute
meningo-encephalitis in which the infiltrating immune cells are
mainly comprised of CD8 T cells, together with less numerous
CD4
+ T cells and macrophages [22,23]. Several studies showing
the preferential presence of CD8 T cells in direct proximity to
neuronal cell lesions and adoptive transfer experiments have
clearly established the central role of CD8 T cells in BDV-induced
encephalitis and neuronal destruction [24–26].
In this study, our goal was to provide further insight on the
specifics on neuron / CD8 T cell interactions in the course of a
natural disease and to determine the ensuing functional conse-
quences. We used BDV-infected primary cultures of neurons,
which were incubated, without any further manipulation, with
CD8 T cells directly extracted from the brains of BDV-infected
Lewis rats. Thereafter, we analyzed the outcome of the cognate
interactions between CD8 T cells and BDV-infected neurons.
Results
BDV infection triggers neuronal MHC I expression
We used cortical neurons prepared from Lewis rat embryos that
had been infected with cell-free BDV one day after plating and
further cultured for 14 days. At this time point, neurons have
established mature synapses [27] and the virus has spread to all of
them, in agreement with our previous findings [28–30]. Detection
of the BDV nucleoprotein using immunofluorescence analysis
(Figure 1A and B) confirmed that the large majority (.95%) of
neurons was positive for BDV antigens and that infection
proceeded without detectable effect on the morphology or viability
of the cultures, consistent with the non-cytolytic replication
strategy of BDV.
We then assessed expression of MHC I molecules on the
neuronal surface, since this is a key prerequisite for antigen
presentation to CD8 T lymphocytes. We used infected and non-
infected neurons, as well as non-infected neurons that had been
treated for 72 h with IFN-c (100 U/ml) and TTX (1 mM), to
induce MHC I expression [13]. We also used non-infected
neurons treated for 72 h with IFN-ß (100 U/ml). Living neurons
still attached to the plastic were stained using a monoclonal
antibody recognizing the rat MHC I RT1-A molecule. After
staining, neurons were rapidly harvested, fixed and further stained
for the intracellular neuronal protein Tau. Flow cytometry analysis
(Figure 1C and D) revealed that cultures contained .98% neurons
and that non-infected neurons expressed little or no MHC I
molecules (0.560.3% positive neurons). As previously published
[13], treatment with IFN-c and TTX strongly induced MHC I
expression (7065% positive neurons). Interestingly, BDV infection
triggered a significant expression of neuronal MHC I (3063.5%
positive neurons). Analysis of fluorescence intensities (Figure 1E)
revealed that levels of surface expression of MHC I induced by
BDV infection were nevertheless lower than those obtained by
neuronal exposure to IFN-c and TTX. Of note, treatment of non-
infected neurons with IFN-ß induced comparable proportion
Author Summary
When a virus infects the brain, it is important to quickly
block viral replication without causing excessive damage
to neurons, which are not easily renewed. Cytotoxic T
lymphocytes (CTL) are one of the main actors for virus
elimination. However, the question of whether CTL are
indeed capable of destroying infected neurons remains
controversial. For this work, we analyzed the characteristics
of interactions between infected neurons and CTL using
neurotropic Borna disease virus (BDV). This virus infects
neurons and triggers severe inflammation in the brain. We
isolated CTL directly from the brains of rats infected with
BDV and analyzed their interaction with primary cultures of
neurons. Using live-cell fluorescence microscopy, we
observed that CTL were arrested upon encounter with
infected neurons and that they established stable contacts
with them. Thereafter, infected neurons exhibited rapid
changes in permeability but remained alive and electrically
active for several hours, before ultimately being destroyed.
Our study shows that neurons can indeed be recognized
by CTL, an important observation for a better understand-
ing of the physiopathology of virus-induced brain inflam-
mation. In addition, it reveals that neurons are relatively
resistant to CTL-induced killing, which may open a window
of opportunity for new treatments.
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infection with BDV.
Thus, BDV infects neuronal cultures efficiently and triggers
significant neuronal MHC I expression. For all subsequent studies,
we used neurons that had been infected for the same length of time
(14 days) and verified for each experiment that infection was
indeed complete prior to any subsequent analysis.
CD8 T cells preferentially infiltrate the CNS upon BDV
infection and express cytotoxic effectors
Lewis rats were sacrificed 14 days after intracerebral infection
with BDV. In previous experiments, we determined that, similar to
others [24,31], this time point corresponded to the peak of the
neurological disease caused by BDV infection and that inflam-
matory infiltrates were most abundant in the brain at this stage
[32]. Consistent with previous reports [24,31], phenotypic
characterization of brain-infiltrating lymphocytes using flow
cytometry revealed that CD8 T cells accounted for 51%61.5%
of all T cells present in the brain (i.e., positive for the TCR),
whereas CD4 T cells represented 30%63% of TCR
+ cells
(Figure 2A). This 1.7 to 1 ratio of CD8 to CD4 cells in the brain
contrasted with the usual 1 to 3 ratio found in cervical lymph
nodes of the same animals, reflecting the high proportion of CD8
T cells recruited to the CNS upon BDV infection. Moreover, this
ratio was probably under-estimated since we detected a high
proportion of TCR
+ cells (<20%) that were negative for both
Figure 1. BDV infection induces MHC I expression on neurons. (A), Immunofluorescence analysis of non-infected (NI) and (B), BDV-infected
neurons, 14 days post infection with cell-free BDV. BDV Nucleoprotein was detected using a rabbit polyclonal antibody, followed by an Alexa 488-
coupled secondary antibody (green), while ßIII-tubulin neuronal protein was detected using a mouse monoclonal antibody, followed by an Alexa
594-coupled secondary antibody (red). (C) Representative dot plot examples of MHC I and neuron-specific Tau expression in non-infected (NI) or BDV-
infected neurons. (D) Quantification of MHC I positive neurons. Data are represented as percentage of Tau
+ neurons expressing MHC I. Results are
expressed as means 6 sem of at least four independent experiments. ***, p,0.001 by Mann-Whitney U-test. (E) Representative fluorescence intensity
profiles for MHC I expression between BDV-infected neurons (green) and non-infected neurons treated with either IFN-b (blue) or IFN-c+TTX (red).
doi:10.1371/journal.ppat.1002393.g001
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CD8 expression upon activation [33]. To further analyze the
phenotype of CD8 T cells, we purified them using cell sorting
(.99% pure), within a few hours after harvesting. We prepared
total RNA from sorted CD8 T cells and analyzed expression of
several genes by real-time quantitative RT-PCR. When compared
to CD8 T cells purified from lymph nodes of the same animals
(Figure 2B), brain-infiltrating lymphocytes expressed high levels of
effector molecules such as IFN-c (300-fold induction on average),
Granzyme B (180-fold induction) or FasL (50-fold induction).
Expression of Perforin mRNA was also significantly elevated,
albeit at lower levels.
To determine the proportion of brain-derived CD8 T cells
specific for BDV, highly purified CD8 T cells were stimulated with
irradiated syngeneic Lewis fibroblasts (infected or not with BDV)
and assayed by FACS for IFN-c production. On average,
25%63% of CD8 T cells were positive for IFN-c following a
48 h-stimulation period, whereas this percentage was of
11%62.5% upon culture with non-infected cells (Figure 2C).
Finally, we assessed whether brain- or lymph node-purified
CD8 T cells secreted cytokines upon incubation with primary
cultures of neurons that were infected with BDV or not. Cytokine
levels in the supernatants were assayed at 48 h with a Luminex
assay specific for 9 rat cytokines. We did not detect any cytokine
above the threshold level of detection of the assay (4.88 pg/ml) in
the supernatants of CD8 T cells purified from lymph nodes. In
contrast, brain-purified CD8 T cells produced high levels of IFN-c
(up to 9 ng/ml) upon culture with infected neurons (Figure 2D).
These cells also produced IL-10, although at levels below those of
IFN-c. Remarkably, levels were also much lower when brain-
Figure 2. Characteristics of brain-purified CD8 T cells from BDV-infected rats. (A) Percentages of CD8
+ versus CD4
+ cells among TCRab
+
cells purified from brain or cervical lymph nodes of infected rats. Values are expressed as means 6 sem of six independent experiments **, p,0.01 by
Mann-Whitney U-test. (B) Determination by real-time quantitative RT-PCR of the relative mRNA levels of IFN-c, Granzyme B (GzmB), Fas-ligand (FasL)
and Perforin in brain-purified CD8 T cells compared to cervical lymph node CD8 T cells of the same animal. Values were normalized for actin mRNA
levels. Values are expressed as means 6 sem of four independent experiments. ***, p,0.001; **, p,0.01; and *, p,0.05 by paired Student’s t-test. (C)
Percentage of IFN-c-producing cells amongst TCRab
+CD8
+ cells after 48h restimulation with BDV-infected (BDV-Lew) or non-infected (NI-Lew) Lewis
fibroblasts, as determined by intracellular FACS staining. Results are expressed as means 6 sem of four independent experiments. *, p,0.05;
**, p,0.01 by Mann-Whitney U-test. (D) Cytokine levels in supernatants of cocultures of CD8 T cells with neurons. Supernatants were assayed after
48 hours of culture using Luminex multiplex kits. Only levels of IFN-c and IL-10 are shown (see Figure S1 for other cytokines). Values are expressed as
mean concentrations 6 sem of four independent experiments. **, p,0.01 by Mann-Whitney U-test.
doi:10.1371/journal.ppat.1002393.g002
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suggesting that cytokine secretion resulted mainly from the
recognition of viral antigens presented by neurons. There were
no significant differences regarding levels of IL-6, IL-17 or TNF-a
(Figure S1), while results were below threshold for IL-4, IL-5, IL-9
and IL-13.
Together, these data show that BDV infection triggers a
prominent recruitment of CD8 T cells in the brain. These cells are
strongly activated, express high levels of effector molecules and
produce large quantities of IFN-c upon interaction with BDV-
infected neurons.
Brain-purified CD8 T cells are arrested upon contact with
infected neurons, which they recognize in an antigen- and MHC I-
dependent manner. To get further insight on the dynamics of
interactions between CD8 T cells and neurons, we stained purified
CD8 T cells with the lipophilic dye PKH-26, added them to
neuronal cultures previously labeled with Calcein-AM and
performed confocal microscopy imaging using a temperature-
controlled imaging setup (Figure 3, video S1 and video S2).
Strikingly, the mobility of CD8 T cells isolated from the brain was
extremely reduced upon incubation with BDV-infected neurons
compared to non-infected ones (Figure 3A and 3B). Indeed, the
Figure 3. Quantitative analysis of CD8 T cell movement behavior in contact with neurons. CD8 T cells purified from the brain of BDV-
infected rats were labeled with PKH-26 (red) and added to Calcein-AM labeled neurons (green) which were non-infected (A) or infected (B) with BDV.
Randomly chosen trajectories of individual cells were automatically tracked using Imaris software. Trajectories are depicted as color-coded tracks to
represent increasing time, from blue (start of imaging) to yellow (end of imaging). A representative imaging session of 15 min is shown in each case.
(C), Determination of average CD8 T cell velocities for the different experimental conditions. Dots represent average cell velocities of individual cells
(200 to 700 cells analyzed depending on the condition, see numbers below the graph), red bars indicate mean values. Analyses were performed using
non-infected neurons (NI), non-infected neurons treated for 48 h with IFN-c+TTX, BDV-infected neurons or BDV-infected neurons treated with
a neutralizing MHC I monoclonal antibody 1 h prior to washes and addition of CD8 T cells. P values were calculated using Kruskal-Wallis test.
***, p,0.001; n.s., not significant. (D) Relative frequencies of brain CD8 T cells as a function of their individual mean velocity, under the different
conditions of culture. Arrows point to the mean velocity for each condition.
doi:10.1371/journal.ppat.1002393.g003
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interval (CI) of mean 2.59 - 3.03) in the presence of infected
neurons compared to 15.27 mm/min, (95% CI 13.00–17.53) with
non-infected ones (Figure 3C and 3D). Furthermore, once
arrested, CD8 T cells established stable interactions with BDV-
infected neurons throughout the whole imaging period (up to
45 min). CD8 T cells were found in apposition to neurites and
neuronal somas. In contrast, the same brain CD8 T cells exhibited
a much more dynamic behavior upon incubation with non-
infected neurons. Induction of MHC I expression at the surface of
non-infected neurons with IFN-c and TTX was not sufficient to
arrest CD8 T cells (mean velocity 14.84 mm/min, 95% CI 11.60–
18.07). Conversely, masking MHC I molecules on BDV-infected
neurons using OX-18 antibody restored a high mobility of CD8 T
cells (16.62 mm/min, 95% CI 14.24–19.00). In addition, relative
frequencies of CD8 T cell moving at various velocities were similar
when comparing non-infected neurons, non-infected neurons
treated with IFN-c and TTX or BDV-infected neurons treated
with anti-MHC I antibody (Figure 3D). Finally, CD8 T cells
purified from cervical lymph nodes of the same infected animals
were highly mobile, regardless of whether they were assayed on
infected or non-infected neurons (video S3 and data not shown).
Collectively, these data show that CD8 T cells freshly purified
from BDV-infected rat brains establish stable conjugates with
infected neurons and that this interaction depends upon both
neuronal infection and MHC I expression.
Intriguingly, a fraction of brain-purified CD8 T cells formed
long projections once arrested on BDV-infected neurons,
reminiscent of the T cell-extended processes (TCEP) recently
described by McDole et al. [34]. These TCEP were 0.5 mm thick
and 50 mm long on average, although we observed projections of
up to 270 mm. Several TCEP were sometimes observed from a
single CD8 T cells and displayed a very dynamic behavior (video
S4). This dynamic behavior was also evidenced by their occasional
rapid contraction (video S5). Such projections were never observed
in CD8 T cells purified from lymph nodes.
Brain purified CD8 T cells induce early changes in neuronal
permeability, associated with increased neuronal electrical activity.
We then sought to analyze the impact of this stable interaction
with CD8 T cells on BDV-infected neurons. When calcein-loaded
infected neurons were incubated with brain-purified CD8 T cells,
we observed the formation of ‘‘axonal beading’’ figures in BDV-
infected neurons, revealed by the formation of calcein dots lining
the neurites, while there were no visible changes in the neuronal
network of control non-infected neurons incubated with brain
CD8 T cells (compare Figure 4A with 4B and video S6 with video
S7 and S8). Upon incubation with CD8 T cells, calcein beading
figures were observed throughout the culture, affecting both
neurites and neuronal somas, without any noticeable proximity
with the sites of CD8 T cell interaction with neurons (video S8). In
order to quantify this phenomenon, neurons were imaged for 45
minutes after addition of brain CD8 T cells and levels of calcein
fluorescence measured at the beginning of the experiment were
subtracted from levels obtained at the end of the incubation. The
resulting differences in fluorescent signals therefore provided a
good estimate of calcein beading (Figure 4C and 4D). While there
were only minimal changes when brain CD8 T cells were applied
to non-infected neurons, we detected significant residual fluores-
cence when using BDV-infected neurons. Consistent with a role of
CD8-neuron cognate interaction in this process, incubation of
BDV-infected neurons with anti-MHC I antibody markedly
decreased calcein beading (Figure 4D).
Given the changes in neuronal morphology consecutive to
incubation with brain CD8 T cells, we next studied its impact on
the electrophysiological properties of neuronal networks. We used
a system based on microelectrode arrays (MEA), which allows to
monitor the firing pattern of a neuronal network grown on a grid
of sixty electrodes embedded in a culture dish (Figure 5A) [35]. We
assessed the impact of incubation with CD8 T cells by measuring
the frequency of grouped action potentials, or bursts, over the
neuronal network (Figure 5B). Before adding CD8 T cells,
spontaneous firing frequencies were similar whether neurons
were infected or not with BDV (0.03760.0008 Hz vs.
0.03860.0011 Hz), in agreement with our previous studies
[28,30]. Upon addition of brain-purified CD8 T cells (at a ratio
of 1 to 1), the electrophysiological properties of non-infected
neurons remained remarkably stable throughout the whole
experiment (0.03860.0038 Hz after 6 h of incubation). In sharp
contrast, the addition of CD8 T cells to BDV-infected neurons
triggered a significant increase of the mean burst frequency, which
doubled to attain 0.07460.0038 Hz. Remarkably, the neuronal
network remained electrically active up to 3 h after addition of
CD8 T cells. Thereafter, we witnessed a decline of the firing
pattern, with neurons becoming nearly completely silent by 6 h of
incubation (Figure 5B).
Longer incubation times with brain-purified T cells lead
to neuronal apoptosis
To explore the basis for this electrical silencing occurring after
longer incubation times with CD8 T cells, we analyzed whether
interaction with CD8 T cells eventually triggered neuronal
apoptosis. The fluorescent probe FLICA, which involves covalent
binding of fluorescent Z-VAD to activated caspases, was used to
detect activation of caspases 3 and 7 in live neurons. The intensity
of fluorescent signals therefore provided a direct quantification of
apoptosis (Figure 6). Consistent with the maintenance of their
electrical activity, we did not detect significant apoptosis in non-
infected neurons, even 4 h after addition of brain CD8 T cells.
BDV-infected neurons did not display any caspase induction up to
2 h after incubation with CD8 T cells, but after 4 h we detected a
strong increase in fluorescence, indicating prominent neuronal
apoptosis. This observation was consistent with the delayed loss of
electrical activity at longer time points of incubation (Figure 5B).
At longer time points, we noted a progressive disaggregation of the
neuronal network, which was however apparent only 6 to 8 hours
after incubation with CD8 T cells (data not shown). Pre-
incubation of BDV-infected neurons with anti-MHC I antibody
significantly reduced neuronal apoptosis (Figure 6), further
indicating that neuronal attack by CD8 T cells is a process which
depends on the recognition of MHC I/viral antigen complexes at
the surface of neurons.
Discussion
Besides their central role in the response to neurotropic viral
infections, CD8 T cells are increasingly being recognized as key
players in the pathogenesis of many neuroinflammatory diseases,
including multiple sclerosis [36–38]. It is thought that CTL act as
effector cells and contribute to tissue damage, based on their
preferential accumulation in parenchymal infiltrates. The modal-
ities of action of CD8 T cells in the CNS and notably the interplay
between immune regulation and pathogen control are, however,
complex and variable. Here, we provide novel information
concerning the modalities of interaction between antiviral CTL
and infected neurons.
Our findings that BDV infection triggers MHC I expression by
neurons were surprising. In general, viruses are better known for
their capacity to down regulate or prevent the expression of MHC
Neurons are Targets for Antiviral CTL
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immunomodulatory viral proteins. Relevant examples of such
proteins include HIV Nef, KSHV MIR1 and MIR2, myxoma
virus MV-Lap or several CMV proteins [39–41]. These
mechanisms of control should theoretically be even tighter in
neurons, which are less prone to express MHC I molecules.
Nevertheless, in the case of Flaviviruses such as West-Nile virus, it
has been previously shown that CD8 T cells could recognize and
destroy infected neurons, although expression of MHC I molecules
was not formally assessed [42,43]. There may be several non-
exclusive mechanisms to explain our findings. First, as impairment
of neuronal electrical activity has been shown to induce MHC I
expression, one hypothesis is that BDV infection may trigger
MHC I expression through its effects on neuronal activity. Indeed,
we have previously shown that BDV can impair synaptic plasticity
[28,30] and these electrophysiological alterations could play a role
in MHC I induction. Alternatively, BDV infection of neurons
could trigger the production of type-1 interferons, which in turn,
could induce MHC I expression. Recent evidence has clearly
demonstrated that neurons can take part to the antiviral defense
by being both IFN-a/ß producers and responders [44]. In
addition, it is now well established that IFN-a/ß can induce
detectable levels of MHC I expression by neurons, although not as
efficiently as IFN-c [1]. The fact that levels of MHC I expression
induced by BDV were similar to those obtained upon exogenous
application of IFN-ß (Figure 1D and 1E) provides indirect
evidence in support of this hypothesis. Also consistent with these
findings, a microarray analysis provided experimental evidence of
a type-1 interferon signature in BDV-infected neurons (Table S1).
We also confirmed our microarray data by demonstrating the up
regulation of interferon-stimulated genes in BDV-infected neu-
rons, by using both real-time quantitative RT-PCR and western
blot analyses (Figure S2). Given that our neuronal cultures were
prepared from embryonic (E18) cortical tissue and further cultured
Figure 4. Interaction with brain-purified CD8 T cells induces early morphological changes of BDV-infected neurons. (A) A
representative BDV-infected neuronal network loaded with calcein AM (green) at the start (t=0 min) and (B) 45 min after coculture with PKH-26
stained brain-derived CD8 T cells. (C) Representative example of the image analysis performed to quantify the formation of calcein beading figures.
Upon subtraction between images shown in (A) and (B), the residual fluorescence signal corresponds to calcein beading. (D) Quantification of the
differences in fluorescence values, expressed as arbitrary units (AU). Values are expressed as means6sem of 5 to 6 independent experiments.
*, p,0.05; **, p,0.01 by Mann-Whitney U-test.
doi:10.1371/journal.ppat.1002393.g004
Neurons are Targets for Antiviral CTL
PLoS Pathogens | www.plospathogens.org 7 November 2011 | Volume 7 | Issue 11 | e1002393for a few weeks, we cannot exclude the possibility that our neurons
may behave differently than fully mature neurons, in particular
regarding their MHC I inducibility.
Even more surprising were our findings that neurons could not
only express MHC I but also present viral antigens CD8 T cells,
triggering the secretion of cytokines such as IFN-c and IL-10.
Figure 5. Analysis of electrical properties of neurons upon contact with brain CD8 T cells. (A) Representative view of cortical neurons
cultured in an MEA dish. Electrodes are spaced by 200 mm; electrode diameter is 30 mm. Original magnification, X50. (B) Quantitative analysis of the
mean burst frequency for non-infected (NI) neurons and BDV-infected neurons upon coculture with brain CD8 T cells (at a ratio of 1:1). The mean
burst frequency was first calculated under spontaneous conditions and at various times after the beginning of coculture. For each condition, data
were acquired from 100 to 460 electrodes, from five independent experiments. Values are expressed as means 6 sem *, p,0.05; ***, p,0.001 by
unpaired Student’s t-test.
doi:10.1371/journal.ppat.1002393.g005
Figure 6. Quantitative analysis of neuronal apoptosis following incubation with brain CD8 T cells. Apoptosis was measured using the
fluorescent probe FLICA, and levels of VAD-FMK fluorescence were determined on 5 randomly selected fields for each condition. This analysis was
performed upon incubation for 2 hours (white bars) or 4 hours (black bars) with brain purified CD8 T cells (at a ratio of 1:1) using non-infected
neurons (NI), BDV-infected neurons, or BDV-infected neurons treated with a blocking MHC I monoclonal antibody 1 h prior to washes and addition of
CD8 T cells. Values are expressed as means 6 sem from 5 separate experiments. ***, p,0.001 by Mann-Whitney U-test.
doi:10.1371/journal.ppat.1002393.g006
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interactions and reveal that neurons can process and present
antigenic peptides to CTL, an aspect which could not be assessed
in experimental systems using peptide-pulsed neurons. This is also
consistent with previous reports showing that neurons express
different components of the molecular machinery required for
epitope processing and MHC I presentation, such as TAP1/TAP2
and LMP2/LMP7 [45,46]. Based on our cytokine secretion data
and imaging studies, antigen processing and MHC I presentation
by neurons are clearly functionally relevant. Indeed, CTL arrest
and the ensuing changes in neuronal permeability and apoptosis
were all significantly prevented or delayed by the addition of an
antibody masking MHC I molecules. Interestingly, brain-infiltrat-
ing CD8 T cells produced the cytokine IL-10 in addition to IFN-c
at the peak of BDV-induced encephalitis. Similar observations
have been made recently in a Coronavirus-induced encephalitis
model [47]. This secretion of IL-10 has been interpreted as a
mechanism protecting critical organs from bystander tissue injury,
while permitting viral clearance [47,48].
Upon CTL arrest, we observed the formation of highly dynamic
structures, designated as TCEP in a recent report studying CD8 T
cells specific for Theiler’s virus [34]. It was suggested that these
dynamic cellular projections could confer a higher motility to
lymphocytes, allowing them to navigate through brain tissue or
sample the microenvironment surrounding the cell. Since such
TCEP have now been described in two separate models of
neurotropic virus infections, it would be important to assess in
future studies whether these modifications of lymphocyte mor-
phology are organ-specific and characteristic of lymphocytes
infiltrating the CNS, or if they are dependent on their engagement
of infected cells within this tissue.
Another interesting aspect concerned the modalities of attack of
CTL against BDV-infected neurons studied by real-time imaging.
Within 45 minutes after CTL addition, we observed changes in
neuronal membrane permeability, revealed by the formation of
calcein dots lining the neurons. These were accompanied by
morphological changes, variably designated as axonal beading or
blebbing by several authors, which appear to represent a general
response of neurons to various stressing insults. In particular, they
have been visualized in neurons following axonal transection and
Wallerian degeneration [49], oxidative stress [50], ischemia [51],
trauma [52] or even allogeneic CTL [53]. Although the
underlying mechanism is not well understood, it seems to be
accompanied by mitochondrial dysfunction and delayed cell
death. Recently, it was suggested that calcein leakage from
neurons following oxygen-glucose deprivation could result from
opening of neuronal hemichannels, a type of half-gap junctions
that form large-conductance channels and allow flux of ions and
molecules [51]. It will be interesting to test whether this is also the
case following CD8 T cell engagement.
Remarkably, despite these early changes in neuronal perme-
ability, the electrical properties of infected neurons were preserved
for a significant duration after addition of brain-purified CTL.
This contrasted with the immediate shutdown of electrical
signaling, both in single neurons and networks, which follows
incubation of OVA peptide-pulsed neurons with primed OT-I
cells, as recently described by Meuth et al. [15]. Since neurons
were killed rapidly upon recognition by highly differentiated CD8
OT-I cells, our observations suggest that impairment of electrical
activity upon CTL encounter may also be dependent on the
intensity of the ‘‘lethal hit’’ delivered by the CTL. Indeed, the
different kinetics of CTL engagement with neurons in our system
is probably related to the fact that CD8 T cells purified for the
brains of BDV-infected rats were not subjected to further in vitro
stimulation and that the neurons were undergoing a natural viral
infection, with the density of MHC I / cognate peptides being
closer to physiological levels.
At present, we can only speculate about the mechanisms of
neuronal death triggered by CTL. CD8 T cells purified from
brains of BDV-infected rats expressed all cytolytic effectors,
including IFN-c, perforin, granzyme-B or FasL. Both Fas/FasL
and perforin/granzyme pathways have been demonstrated to be
effective against neurons upon engagement with CTL [14,54,55].
Since cell death appears to develop with slower kinetics when
triggered through the Fas/FasL pathway [56,57], given our
observations that BDV-infected neurons are still electrically active
after three hours, we would favor the hypothesis that killing of
BDV-infected neurons preferentially occurs by this route.
However, previous studies in the rat model of BDV infection
have also shown expression of perforin mRNA in the brain [24].
Alternatively, the relatively low density of MHC I expression
triggered by infection, together with a restricted expression of
perforin could lead to a limited release of cytolytic granules
towards the infected neurons. Finally, protection against excessive
apoptosis may also be conferred by BDV infection per se.
Recently, it was shown by Poenisch et al. that the BDV X protein
could protect cells against Fas-mediated apoptosis in vitro [58]. In
our system, however, the kinetics or characteristics of CTL-
induced apoptosis were unchanged when we used neurons infected
with the BDV-X(A6A7) mutant [58], which has lost its capacity to
block Fas-induced apoptosis in vitro, resulting from loss of the
mitochondrial localization of the X protein (Figure S3).
Our findings have several important implications. First, we
confirmed the capacity of neurons to process and viral antigens
during the course of a natural infection, leading to simulation of
CD8 T cells and production of inflammatory cytokines. Therefore,
beyond being the mere targets of CD8-mediated cytotoxicity,
neurons may play an active part in the development of CNS
inflammation through T cell activation and cytokine release.
Second, the slow kinetics of neuronal death suggests that this
progressive neuronal loss of function may leave open a window of
opportunity for future treatments. Very recently, it was shown that
the immune-mediated axonal damage that develops during
autoimmune encephalomyelitis (in mice) or multiple sclerosis (in
humans) was a slow and likely reversible process [59]. These
authors described this process as ‘‘focal axonal degeneration’’,
beginning with axonal swelling and mitochondrial dysfunction,
very reminiscent of the axonal beading phenomenon described
herein. A better understanding of the mechanisms involved in our
system may provide novel putative targets that could then be




This study was carried out in strict accordance with EU
regulations and with the recommendations of the French national
chart for ethics of animal experiments (articles R 214- 87 to 90 of
the ‘‘Code rural’’). The protocol was approved by the committee
on the ethics of animal experiments of the re ´gion Midi Pyre ´ne ´es
and by IFR 150 (permit numbers: 04-U563-DG-06 and MP/18/
26/04/04). All procedures were performed under deep anesthesia
as described below and all efforts were made to minimize suffering.
Primary culture of neurons and viral infection
Primary cortical neurons were prepared from Lewis rat embryos
at gestational day 18 using a previously described procedure
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cortex tissue was dissociated by incubation for 15 min at 37uCi n
phosphate buffer saline (PBS) containing 10 U/ml Papain
(Worthington), followed by gentle dissociation in PBS containing
1.5 mg/ml BSA and 1.5 mg/ml Trypsin inhibitor (from chicken
egg, Sigma). Cultures were maintained in serum-free Neurobasal
medium (Invitrogen) supplemented with 0.5 mM glutamine, 1%
penicillin/streptomycin and 2% B-27 supplement (Invitrogen).
Plating was performed on variable supports depending of the use
(Lab-Tek chambered coverglass, Nunc, culture dishes or glass
coverslips), all previously coated with poly-ornithine (Sigma) and
Laminin (Roche). One day after plating, half of the cultures were
infected with cell-free BDV (Giessen strain He/80). Cell-released
virus stocks were prepared as described [60,61], using persistently
infected Vero cells. By 14 days post-infection, BDV infection of
neurons was verified by immunofluorescence for each experiment
using an anti-BDV nucleoprotein serum.
Infection of rats
Female Lewis rats (4-week-old) were obtainedfrom Janvier SAS
(Le Genest St Isle, France) and maintained in our animal facility.
The day of infection, rats were anesthetized with a mixture of
ketamine (50 mg/kg of body weight) and xylazine (15 mg/kg of
body weight). They were inoculated intracranially with 50 mlo fa
20% (w/v) stock of BDV-infected rat brain homogenate,
corresponding to 1000 focus-forming units of BDV. We used the
fifth brain passage in newborn rats of the Giessen strain He/80.
To minimize reflux along the injection tract, the needle was left in
place for 20 seconds before being slowly withdrawn.
Isolation of brain mononuclear cells (BMCs)
BMCs were isolated by a method adapted from previously
described procedures [24,32,62]. Briefly, rats were deeply
anesthetized and perfused with 50 ml of PBS through the left
ventricle to remove blood from the organs. Brains were collected
in Hank’s buffered salt solution (HBSS) containing 20 mM Hepes
(HH) and dissociated using a glass Potter. Brain suspensions were
enzymatically digested for 1 hour at 37uC in HH containing
collagenase D (1 mg/ml), trypsin inhibitor (TLCK, 0.5 mg/ml)
and DNase I (10 mg/ml). The digested suspensions were filtered
(70 mm cell strainer, Falcon), pelleted and resuspended in 30 ml of
30% Percoll (Pharmacia). This solution was carefully placed on top
of 10 ml of 70% Percoll and centrifuged for 30 min at 2000 rpm
at 20uC. BMCs were collected at the interface between the 30%
and 70% Percoll layers, extensively washed with RPMI 1640 me-
dium (Invitrogen) and directly used for FACS staining and cell
sorting. Cell suspensions were also prepared from the cervival
lymph nodes of the same animals, filtered as above, washed with
PBS containing 5% fetal calf serum (FCS) and kept on ice until
FACS staining and cell sorting.
Flow cytometry and cell sorting
The monoclonal antibodies (mAbs) used were as follows: PE-
conjugated anti-rat TCRab (clone R73) (PharMingen, San Diego,
CA); anti-rat CD8b (clone 3.4.1) either FITC-conjugated
(PharMingen, San Diego, CA) or Alexa 647-conjugated (Biole-
gend). For staining, BMCs or lymph node cells (LNC) were
suspended in FACS buffer (consisting of PBS with 5% FCS)
containing the different mAbs and incubated for 20 min at 4uC.




high) expression using a
FACS Aria II-Sorp (BD Biosciences). The purity of the cells was
always higher than 99%. Flow cytometry data were collected on
FACSCalibur or LSRII cytometers (BD Biosciences) and analyzed
using FlowJo software (TreeStar, version 8.8.6).
Assessment of MHC I expression on neurons by flow
cytometry
Neurons grown on 35 mm dishes were washed with Tyrode’s
solution (119 mM NaCl, 5 mM KCl, 2 mM CaCl2,2 m M
MgCl2, 25 mM Hepes, 30 mM glucose) prior to incubation at
4uC for 45 min with 5 mg/ml of purified anti-rat MHC I antibody
(RT1-A, clone OX18), under gentle agitation. After several washes
with Tyrode’s solution, neurons were rapidly detached from the
dish using 0.5% Trypsin, washed with PBS and blocked with PBS
containing 2.5% FCS and 5 mM EDTA. The collected neurons
were fixed and permeabilized using Cytofix/Cytoperm and Perm/
Wash buffers (Becton Dickinson), according to the manufacturer’s
instructions and processed for staining at room temperature for
1 hour with anti-Tau antibody (Sigma-Aldrich). Neurons were
washed twice in Perm/Wash buffer before FACS analysis. To
induce MHC I expression, non-infected neurons were treated with
either 100 U/ml mouse IFN-c (Biosource) plus 1 mM Tetrodo-
toxin (TTX, Sigma), or 100 U/ml rat IFN-ß (PBL interferon
source). Reagents were added to the culture medium 48 hrs before
analysis of MHC I expression as described above.
Analysis of cytokine production
IFN-c levels were assessed by intra-cytoplasmic staining,
essentially as described [63]. Briefly, BMCs or LNC were
stimulated by coculture with irradiated Lewis fibroblasts (a gift
from Pr. L. Stitz, Tu ¨bingen, Germany), either infected or not with
BDV, in complete RPMI 1640 medium containing 10% FCS, 1%
sodium pyruvate, 1% non essential amino acids, 1% L-glutamine,
1% penicillin-streptomycin, 2610
25 M 2-mercaptoethanol, and
50 U/ml recombinant human IL-2 (AbCys). After 24 hours,
GolgiPlug (1 ml/ml, BD Biosciences) was added in the medium
and cultures were further incubated overnight. Thereafter, cells
were labeled for membrane expression of TCR and CD8ß and for
intra-cytoplasmic production of IFN-c using DB1-FITC mAb (a
gift from Dr. A. Saoudi, Toulouse, France) and analyzed by flow
cytometry.
Cytokine levels were also measured in the supernatants as
follows: directly after cell sorting, CD8 T cells purified from the
brain or lymph nodes (1.5610
5 cells/well) were incubated with
BDV-infected or non-infected neurons grown in 96-well culture
plates (Falcon, Becton Dickinson). Forty-eight hours after
coculture, cytokine production (IL-4, IL-5, IL-6, IL-9, IL-10, IL-
13, IL-17, IFN-c and TNF-a) was examined in the cell
supernatants by Luminex multiplex immunoassay (Millipore).
Immunofluorescence
Standard immunofluorescence was performed as described
previously [29]. Briefly, neurons grown on glass coverslips were
fixed for 20 min at room temperature with 4% paraformaldehyde,
permeabilized using PBS + 0.1% Triton-X100 during 4 min,
rinsed with PBS, and blocked overnight at 4uC with PBS + 2%
normal goat serum. Incubation for 1 h at room temperature or
overnight at 4uC with primary antibodies was followed, after
several washes in PBS, by a 1-h incubation at room temperature
with secondary antibodies. After extensive washing, coverslips
were mounted using ProLong Gold (Molecular Probes).
RNA preparation and analysis
Total RNA was isolated from highly purified CD8 T cells using
the RNeasy Minikit (Qiagen, Courtaboeuf, France). Reverse
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random hexamer primers (0.1 mg) (Gibco BRL), and SuperScript
Reverse Transcriptase (200 U; Gibco BRL). cDNAs were stored at
220uC until use.
Quantitative cDNA amplification was performed according to
manufacturer’s instructions. The products of polymerase chain
reaction (PCR) LightCycler amplification were detected with
SYBR green I dye (Roche Diagnostics). PCR cycling conditions
were 50uC for 2 minutes and 95uC for 10 minutes, followed by 40
cycles of 95uC for 15 seconds, 60uC for 1 minute, followed by the
final melting curve program. The melting curve analysis of PCR
products together with their analysis by electrophoresis revealed
the presence of a single amplicon at the expected size. Each
sample was run in duplicate and mean values were used for
quantitation.
Relative quantification of mRNA concentrations was performed
with the standard curve method, with amplification of target
mRNA and actin mRNA for normalization. The relative amount
of mRNA in each sample was calculated as the ratio between the
target mRNA and the corresponding endogenous control actin
mRNA.
The primers used were as follows. IFN-c:5 9-GCCAAGTTC-
GAGGTGAACAAC-39,5 9-TTCATTGACAGCTTTGTGCT-







Labeling of cells for imaging
Aftercell sorting tohigh purity(.99%),CD8T cellswerelabeled
withPKH-26 red fluorescent cell linker kit (Sigma), according to the
manufacturer’s instructions. Briefly, cells were stained with 4 mM
PKH-26 at room temperature for 5 min, the reaction was stopped
by adding FCS and cells were washed once in complete RPMI
medium containing 10% FCS. In parallel, neurons grown on
Labtek chambered coverglass were labeled with 1 mM calcein-AM
(Molecular Probes) in neuronal medium for 30 min at 37uC.
Neurons were then washed twice with Tyrode’s solution.
Time-lapse confocal microscopy
Fluorescence measurements and imaging were performed on a
Zeiss LSM-510 inverted confocal microscope with 10X, 20X or
40X objectives, whilst maintaining the cells at 37uC and 5% CO2.
To minimize photobleaching, one frame was captured every 20 s
on average. Single-cell-tracking analysis was performed automat-
ically (intensity .130620; size <10 mm) with Imaris sotware and
only tracks with durations of .120 s were included in the analysis.
Image sequences of the time-lapse recordings were processed using
Metamorph and Imaris softwares and 3-D images were generated
with Imaris.
Quantification of neuronal beading
For each movie, the first picture in the green channel (correspond-
ing to neuronal staining) was subtracted from the last one (45 min
later) in order to obtain the difference in green fluorescence due to the
formation of beads between these two time points.
Assessment of neuronal apoptosis
After coculture with CD8 T cells, neurons were washed with
neuronal culture medium and labeled with Image-iT LIVE Green
Caspase Detection Kit (Molecular Probes) which provides FLICA
reagent specific for caspase-3 and -7. Staining was performed
according to the manufacturer’s recommandations. At different
times after incubation, levels of fluorescence intensities were
measured on microsopic fields chosen at random.
Electrophysiology
Neuronal cortical cultures were prepared from Lewis rats as
described above and seeded at a density of 10
5 cells on multi-
electrode arrays (MEA, Multi Channel Systems GmbH, Reutlin-
gen, Germany). Half of the MEA dishes were infected with BDV
on day 1. After addition of highly purified CD8 T cells (at a ratio
of one CD8 T cell per neuron), signals corresponding to the
electrical activity from the 60 electrodes of the MEA were
recorded using the MC Rack Software (Multi Channel Systems
GmbH, Reutlingen, Germany), which allows both online
visualization and raw data storage. The signal corresponding to
the firing of a single action potential by a neuron in the vicinity of
an electrode was identified as a spike. We also detected high
frequency grouped spikes trains, known as bursts, which represent
an important parameter of the analysis of neuronal network
activity [64]. Bursts were defined as a series of more than 3 spikes
occurring in less than 100 ms. Spikes and bursts were detected by
a dedicated analysis software developed at INSERM U862
(Bordeaux, France) [35], which computes the signal obtained
from the electrodes, calculates a threshold and detects a spike
every time the signal crosses this threshold with a negative slope.
The threshold was set to a minimum of three standard deviations
of the average noise amplitude computed over the whole recording
and applied from the signal averaged value as a baseline [65]. For
each time point, recordings were performed over a 3 min period,
and the mean burst frequency was calculated by averaging the
results obtained for all electrodes.
Data analysis
Comparisons between groups were performed with different
statistical tests (Student’s t-test, Mann-Whitney U-test or Kruskal-
Wallis) using the GraphPad Prism software.
Supporting Information
Figure S1 Analysis of cytokine levels for IL-6, IL-17 and TNF-a
in supernatants of cultures of CD8 T cells with neurons, either
infected with BDV or not. Supernatants were assayed after
48 hours of culture using Luminex multiplex kits. Levels of IL-4,
IL-5, IL-9, IL-13 were below the detection threshold of our assay
(4.88 pg/ml). Values are expressed as mean concentrations 6 sem
of four independent experiments.
(TIFF)
Figure S2 Analysis of expression of interferon-related genes in
BDV-infected neurons. (A) Determination by real-time quantita-
tive RT-PCR of the relative mRNA levels of genes listed at the
bottom of the graph in BDV-infected neurons compared to non-
infected ones. Values are normalized for GAPDH mRNA levels.
Values are expressed as means 6 sem of three independent
experiments. Primer sequences used for RT-PCR are available on
request. (B) Western blot analysis. Equivalent protein amounts of
non-infected (NI) or BDV-infected neurons were analyzed by
western-blot with specific antibodies for STAT-1 and Mx1.
Expression of GAPDH was used to normalize expression.
Peroxidase activity was revealed using the Supersignal West Pico
Chemiluminescent substrate (Pierce) and quantification was
performed by densitometry using Scion Image software (Scion
Corporation). Bottom graph shows the quantification of three
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percentage of increase relative to NI neurons. Values are
expressed as means 6 sem.
(TIFF)
Figure S3 Neurons infected with the BDV-X(A6A7) mutant do
not exhibit significant change in the susceptibility to apoptosis
triggered by CD8 T cells. Neuronal apoptosis was quantified as
described in Figure 6, following incubation for 4 hours with brain
CD8 T cells (at a ratio of 1:1). Levels of VAD-FMK fluorescence
were determined on 5 randomly selected fields for each condition.
This analysis was performed upon incubation of brain purified
CD8 T cells with non-infected neurons, neurons infected with
wild-type BDV or the BDV-X(A6A7) mutant, as well as BDV-
infected neurons treated with a neutralizing MHC I monoclonal
antibody 1 h prior to washes and addition of CD8 T cells. One
representative experiment out of two is shown.
(TIFF)
Table S1 Genes most highly induced in BDV-infected neurons
as determined by microarray analysis. The table shows only the
genes for which the difference between control (non-infected) and
BDV-infected neurons was of more that 2-fold. Genes indicated in
bold characters correspond to genes related to the interferon
pathway. FC: fold change; N/A not available. For microarray
analysis, total RNA was extracted from BDV-infected and non-
infected neurons after 13 days in culture using an RNeasy mini kit
as described in the materials and methods. Triplicate samples were
obtained for each condition. RNA quality was verified using
nanochips on an Agilent 2100 bioanalyzer (Agilent). Gene
expression profiles were analyzed using Affymetrix microarrays
for the rat genome (RAE230 v2.0). Analysis was performed using
the Affymetrix platforms of ‘‘Ge ´nopo ˆle Ile de France’’ for RNA
labeling and hybridization. Statistical analysis was performed with
the Toulouse Genopole (http://genopole-toulouse.prd.fr/).
(DOC)
Video S1 Representative example of the behavior of brain-
purified CD8 T cells incubated with non-infected neurons. CD8 T
cells purified from the brains of BDV infected rats were labeled
with PKH-26 (red) and added to calcein-loaded, non-infected
neurons. Movie is based on one image capture every 20 s using a
10X objective. Trajectories of CD8 T cells are depicted as color-
coded tracks to represent increasing time, as described in the
legend of figure 3. Time counter and scale bar are inserted at the
bottom left of the video. Note the highly mobile and scanning
behavior of CD8 T cells.
(MP4)
Video S2 Representative example of the behavior of brain-
purified CD8 T cells incubated with BDV-infected neurons.
Movie acquisition and analysis was as described for video S1. Note
the reduced mobility of CD8 T cells in contact with BDV-infected
neurons.
(MP4)
Video S3 Representative example of the behavior of CD8 T
cells purified from the cervical lymph nodes of a BDV infected rat
and incubated with BDV-infected neurons. Movie acquisition and
analysis was as described for video S1. Lymph node purified CD8
T cells are very mobile, even in contact with BDV-infected
neurons.
(MP4)
Video S4 Morphological features of a brain-purified CD8 T cell
in contact with BDV-infected neurons. CD8 T cells were labeled
with PKH-26 (red) and added to neurons as described for video
S1. This video shows a closer view of one CD8 T cell to illustrate
the formation of T cell extended projections (TCEP) displaying a
dynamic behavior. The focus of the microscope was set on the
CD8 T cell to visualize the projections and the neuronal network is
consequently less visible. Time counter and scale bar are inserted
at the bottom left of the video.
(MP4)
Video S5 Projections of brain-isolated CD8 T cells are very
dynamic and can rapidly retract. PKH-26-labeled CD8 T cells
isolated from the brain were incubated with BDV-infected
neurons. The video setup and analysis is similar to that described
for video S4. Time counter and scale bar are inserted at the
bottom left of the video. The projection of a T cell interacting with
a neuronal soma, is clearly visible for .15 min and then rapidly
retracts in less than 2 min.
(MP4)
Video S6 Incubation of brain-purified CD8 T cells with non-
infected neurons does not impair neuronal network. PKH-26-
labeled brain-derived CD8 T cells were added to calcein-loaded,
non-infected neurons and examined as described in video S1. A
representative sequence of .1 hr is shown (time counter and scale
bar are inserted at the bottom left of the video), during which no
changes resulting from CD8 T cell scanning were noted on the
neuronal network.
(MP4)
Video S7 Incubation of brain-purified CD8 T cells with BDV-
infected neurons triggers calcein beading. PKH-26-labeled brain-
derived CD8 T cells were added to calcein-loaded, BDV-infected
neurons and examined as described in video S2. In this
representative sequence the networks appears normal for up to
30 min after incubation with CD8 T cells, followed by the
progressive beading of neuronal calcein staining. Time counter
and scale bar are inserted at the bottom left of the video.
(MP4)
Video S8 4-D reconstruction using Imaris software (38 minute-
capture movie, accelerated 280 x) of the interaction between
brain-derived CD8 T cells (labeled with PKH-26, red) and
infected neurons (labeled with calcein-AM, green), similar to that
shown on movie S7. The calcein beading figures consecutive to the
interaction with CD8 T cells occur throughout the neuronal
network and on cell somas, with no specific localization with the
sites of CD8 T cell binding.
(MP4)
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